X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6728) 6728
Publication (469) 469
Newsletter (147) 147
Book Review (106) 106
Book Chapter (49) 49
Book / eBook (37) 37
Conference Proceeding (8) 8
Dissertation (8) 8
Magazine Article (6) 6
Newspaper Article (6) 6
Data Set (4) 4
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3856) 3856
animals (2792) 2792
index medicus (2710) 2710
phospholipids (2518) 2518
male (2186) 2186
female (1901) 1901
lipids (1162) 1162
pharmacology & pharmacy (1099) 1099
adult (947) 947
middle aged (930) 930
rats (924) 924
mice (906) 906
phospholipids - metabolism (899) 899
phospholipids - blood (739) 739
biochemistry & molecular biology (635) 635
research (614) 614
medicine (604) 604
aged (601) 601
proteins (601) 601
phospholipids - therapeutic use (597) 597
phospholipids - chemistry (569) 569
multidisciplinary sciences (554) 554
research article (523) 523
liposomes (515) 515
metabolism (515) 515
cancer (493) 493
cholesterol (489) 489
cholesterol - blood (484) 484
science (466) 466
analysis (436) 436
health aspects (414) 414
triglycerides - blood (411) 411
article (404) 404
fatty acids (399) 399
physiological aspects (394) 394
apoptosis (379) 379
lipid metabolism (370) 370
cell biology (362) 362
biochemistry (351) 351
drug delivery systems (332) 332
oncology (322) 322
inflammation (321) 321
time factors (314) 314
care and treatment (312) 312
biology (309) 309
in-vitro (306) 306
drugs (304) 304
cell line, tumor (290) 290
oxidative stress (287) 287
phospholipids - analysis (286) 286
cells (276) 276
atherosclerosis (270) 270
rodents (268) 268
infant, newborn (266) 266
lipids - blood (265) 265
treatment outcome (265) 265
chemistry, multidisciplinary (264) 264
nutrition & dietetics (261) 261
disease models, animal (259) 259
liver - metabolism (256) 256
nanoparticles (253) 253
membranes (251) 251
adolescent (249) 249
phospholipid (248) 248
rabbits (239) 239
signal transduction (236) 236
pulmonary surfactants - therapeutic use (235) 235
particle size (234) 234
immunology (233) 233
medicine, research & experimental (231) 231
in-vivo (229) 229
physiology (229) 229
enzymes (228) 228
cholesterol - metabolism (226) 226
studies (220) 220
gene expression (219) 219
risk factors (219) 219
plasma (218) 218
rats, wistar (217) 217
dose-response relationship, drug (216) 216
rats, sprague-dawley (216) 216
chemistry, medicinal (213) 213
liver (213) 213
expression (210) 210
tumors (209) 209
liposomes - chemistry (207) 207
diet (205) 205
mice, inbred c57bl (200) 200
pregnancy (200) 200
metabolites (199) 199
chemistry (198) 198
disease (198) 198
phospholipids - administration & dosage (197) 197
activation (196) 196
lipoproteins (196) 196
hematology (195) 195
kinases (195) 195
therapy (192) 192
usage (190) 190
mass spectrometry (187) 187
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6322) 6322
Russian (187) 187
German (172) 172
Italian (89) 89
French (53) 53
Polish (25) 25
Japanese (23) 23
Spanish (23) 23
Ukrainian (19) 19
Chinese (13) 13
Bulgarian (10) 10
Romanian (7) 7
Swedish (6) 6
Norwegian (5) 5
Czech (4) 4
Danish (2) 2
Dutch (2) 2
Hungarian (2) 2
Serbian (2) 2
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Nanomedicine, ISSN 1176-9114, 03/2015, Volume 10, pp. 1791 - 1804
Background: Effective anticancer drug delivery to the tumor site without rapid body clearance is a prerequisite for successful chemotherapy.... 
Phospholipid | Murine breast cancer chemotherapy | Nanoparticles PEG-b-PCL | Paclitaxel | nanoparticles PEG-b-PCL | paclitaxel | POLYMERIC MICELLE FORMULATION | CREMOPHOR-FREE | murine breast cancer chemotherapy | NANOSCIENCE & NANOTECHNOLOGY | GENEXOL-PM | PHASE-II TRIAL | PH-SENSITIVE LIPOSOMES | IN-VIVO | PHARMACOLOGY & PHARMACY | ANTICANCER DRUGS | phospholipid | CHAIN-LENGTH | TARGETED DELIVERY | Cell Survival - drug effects | Paclitaxel - pharmacology | Nanoparticles - chemistry | Polyethylene Glycols - pharmacokinetics | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Antineoplastic Agents - chemistry | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Polyethylene Glycols - therapeutic use | Lactones - pharmacology | Lactones - therapeutic use | Paclitaxel - chemistry | Animals | Lactones - pharmacokinetics | Nanoparticles - therapeutic use | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Mice | Drug Delivery Systems - methods | Lactones - chemistry | Polyethylene Glycols - pharmacology | Nanoparticles | Drugs | Usage | Drug delivery systems | Breast cancer | Research | Chemical properties | Drug therapy | Vehicles | Biomedical materials | Nuclear magnetic resonance--NMR | Polyethylene glycol | Efficiency | Lipids | FDA approval | Polymers | Cholesterol | Chromatography
Journal Article
Journal Article
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 05/2012, Volume 52, Issue 9, pp. 1658 - 1665
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1465-1858, 2005, Issue 2, p. CD002859
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 10/2013, Volume 39, Issue 10, pp. 1683 - 1694
Parenteral lipid emulsions (LEs) are commonly rich in long-chain triglycerides derived from soybean oil (SO). SO-containing emulsions may promote systemic... 
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Soybean oil reducing strategies | Critically ill | Intensive / Critical Care Medicine | Alternative lipid emulsions | Anesthesiology | SURGICAL-PATIENTS | RANDOMIZED CONTROLLED-TRIAL | MEDIUM-CHAIN TRIGLYCERIDES | TOTAL PARENTERAL-NUTRITION | SOYBEAN OIL EMULSION | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | CARE-UNIT PATIENTS | FISH-OIL | SEVERE ACUTE-PANCREATITIS | CRITICAL CARE MEDICINE | Lecithins - administration & dosage | Emulsions - therapeutic use | Fat Emulsions, Intravenous - adverse effects | Immune System - physiology | Emulsions - adverse effects | Humans | Oxidative Stress - physiology | Fat Emulsions, Intravenous - chemistry | Fish Oils - adverse effects | Safflower Oil - administration & dosage | Fish Oils - therapeutic use | Emulsions - administration & dosage | Parenteral Nutrition - methods | Soybean Oil - administration & dosage | Adult | Fish Oils - administration & dosage | Triglycerides - therapeutic use | Databases, Bibliographic | Plant Oils - administration & dosage | Phospholipids - therapeutic use | Triglycerides - adverse effects | Phospholipids - adverse effects | Safflower Oil - adverse effects | Intensive Care Units | Lecithins - adverse effects | Parenteral Nutrition - adverse effects | Safflower Oil - therapeutic use | Phospholipids - administration & dosage | Lecithins - therapeutic use | Treatment Outcome | Soybean Oil - therapeutic use | Inflammation - etiology | Plant Oils - therapeutic use | Plant Oils - adverse effects | Randomized Controlled Trials as Topic | Soybean Oil - adverse effects | Triglycerides - administration & dosage | Immune System - drug effects | Critical Illness - therapy | Inflammation - prevention & control | Oxidative Stress - drug effects | Fat Emulsions, Intravenous - therapeutic use | Care and treatment | Research | Health aspects | Soy oil | critically ill | alternative lipid emulsions | soybean oil reducing strategies
Journal Article